2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$95.49-$0.27 (-0.28%)
Price as of Nov 12, 2026 9:54 AM EST- $4.0BMarket Cap
- 135.98%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$95.49-$0.27 (-0.28%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $95.76 | ||
Change | +$0.74 (+0.78%) | ||
Open | $95.75 | ||
High | $96.15 | ||
Low | $93.48 | ||
Previous Close | $95.02 | ||
Volume | 581,161 | ||
30-Day Average Volume | 949,534 | ||
1-Week Change | -0.37% | ||
1-Month Change | 20.03% | ||
1-Year Change | 135.98% | ||
3-Year Change | 563.16% | ||
5-Year Change | 623.26% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $983.2M | ||
Market Cap | $4.0B | ||
Enterprise Value | $3.9B | ||
Period: QTR TTM FY | |||
Revenue | $286.0M | ||
Net Income | $47.3M | ||
Free Cash Flow | $47.4M | ||
EBIT | $59.1M | ||
EBITDA | $59.5M | ||
Net Working Capital | $558.2M | ||
EPS | $0.56 | ||
Enterprise Value/EBITDA | 66 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 6 | ||
P/E | 171 | ||
PEG | 2 | ||
Price/Free Cash Flow | 85 | ||
Price/Operating Cash Flow | 85 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue